Category — Off Label Use
FDA’s Draft Guidance Regarding the Promotion of FDA-Regulated Medical Products Using the Internet and Social Media Leaves Some Questions Unanswered
Feb. 3, 2012 – The FDA’s long-awaited draft Guidance for Industry on social media provides non-binding recommendations regarding how manufacturers and distributors of prescription drugs and medical devices can respond to unsolicited requests for off-label information, but does not provide guidelines for appropriate responses to other consumer inquiries or comments posted on Facebook and other electronic media. [Read more →]
February 3, 2012 Comments Off
